CheriGeistPAMPAP, PA-C, FAAPA

Neurosurgery • Tarzana, CA

Neurosurgical Physician Assistant

Join to view full profile

Cheri Geist, PA is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Cheri Geist's full profile

Already have an account?

Summary

Cheri Geist, PA-C, MPAP, FAAPA, is a board-certified neurosurgical physician assistant who is passionate about providing the highest level of comprehensive, multi-disciplinary individualized care. Her sunny demeanor is rooted in Southern California, where she earned her PA degree from USC Keck School of Medicine, and completed a decade of neuroimaging research at UCLA. She is a member of the American Association of Neurological Surgeons (AANS) and American Academy of Physician Assistants (AAPA). With Dr. Fox, she synergistically provides spinal evaluations while maximizing treatment outcomes, restoring patient's mobility, and improving quality of life.

In her free time, she enjoys hiking with her dog, practicing aerial acrobatics, and spending time with family.

Hospital Affiliations

Providence Cedars-Sinai Tarzana Medical CenterTarzana, California

Education & Training

Keck School of Medicine of USCMPAP, Physician Assistant, 2012 - 2015
University of Southern CaliforniaPhysician Assistant, 2015
UCLABS, Biology, Magna Cum Laude, 2000 - 2004

Awards, Honors, & Recognition

First Place: Oncology Track at Society of Nuclear Medicine Annual Meeting Society of Nuclear Medicine, 2010

Professional Memberships

American Academy of Physician Assistants - AAPA
Member
National Commission on Certification of Physician Assistants - NCCPA
Member
American Association of Neurological Surgeons (AANS)
Member

Publications & Presentations

PubMed

87 citations
Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
Johannes Schwarzenberg, Johannes Czernin, Timothy F. Cloughesy, Benjamin M. Ellingson, Whitney B. Pope
Clinical Cancer Research. 2014-07-01
99 citations
3′-Deoxy-3′-18F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab
Johannes Schwarzenberg, Johannes Czernin, Timothy F. Cloughesy, Benjamin M. Ellingson, Whitney B. Pope
Journal of Nuclear Medicine. 2012-01-01
291 citations
Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pi...
Wei Chen, Sibylle Delaloye, Daniel H.S. Silverman, Cheri Geist, Johannes Czernin
Journal of Clinical Oncology. 2007-10-20

Books/Book Chapters

PET in the Evaluation of Alzheimer’s Disease and Related Disorders
Chapter: Interpretive Practice Atlas
Page 151 - 210Silverman DHS, Lau V, Geist C, Siu EEditors: Silverman DHS.Springer, New York2009
The Effects of Estrogen on Brain Function
Chapter: Clinical data on estrogen effects in the central nervous system
Page 79 - 94Silverman DHS, Geist CL, Rasgon NLEditors: Rasgon NL.The Johns Hopkins University Press, Baltimore2006

Abstracts/Posters

Metabolic tumor volume by 18F-FDOPA PET is predictive of treatment response in patients with recurrent high-grade gliomas on anti-angiogenic therapy as early as 2 week...
Schwarzenberg J, Cloughesy T, Czernin J, Ellingson B, Pope W, Silverman D, Geist C, Phelps M, Chen W., J Nucl Med., 1/1/2012
Effects of adjuvant therapy on cerebral function during short-term and long-term memory tasks
Nguyen A, Geist C, Ganz P, Kwan L, Castellon S, Irwin M, Bower J, Czernin J, Phelps M, Silverman D., ) J Nucl Med., 1/1/2012
Longitudinal changes in regional brain metabolism associated with endocrine therapy in prospectively studied breast cancer (BC) patients
Pomykala K, Geist C, Ganz P, Kwan L, Castellon S, Cheng I, Irwin M, Czernin J, Phelps M, and Silverman D, J Nucl Med, 1/1/2012
Prescription pattern of Alzheimer-specific drugs is positively associated with immediate release of brain PET scan data in the Metabolic Cerebral Imaging in Incipient ...
Chew J, Geist C, Pomykala K, Foster N, Hoffman J, Dennett K, Zamrini E, Czernin J, Phelps M, Silverman D., J Nucl Med., 1/1/2012
Regional PET activations with trigeminal nerve stimulation (TNS) and correlation with therapeutic response
Schrader LM, Geist CL, DeGiorgio C, Silverman D, Miller P, Susselman MK, Cook IA, Epilepsy Curr, 1/1/2012
The association between aromatase inhibition (AI), cognitive function, and PET metabolism
Hardt M, Silverman D, Patel S, Geist C, Somlo G, Mortimer J, Luu T, Ramani R, Katheria V, Hansen K, Brown J, Jayani R, Chuang C, Hurria A, International Cognition and Cancer Task Force, 1/1/2012
Cerebral Function after Breast Cancer Treatment
Pomykala K, Geist CL, Ganz P, Cheng I, Kwan L, Castellon SA, Breen EA, Bower JE, Irwin MR, Czernin J, International Cognition and Cancer Task Force., 1/1/2012
Prescription of Alzheimer’s-specific drugs and long-term preservation of language function are positively associated with early release of regional cerebral metabolic ...
Silverman D, Chew J, Geist C, Pomykala K, Lu P, Foster N, Hoffman J, Dennett K, Czernin J, Phelps M., Alzheimer’s and Dementia,, 1/1/2012
Objective neuropsychologic performance is associated with levels of medial frontal, temporal, cerebellar activity in brains of breast cancer patients soon after adjuva...
Geist C, Pomykala K, Silverman D, Ganz P, Kwan L, Bower J, Czernin J, Phelps M, Castellon S., J Nucl Med., 1/1/2011
18F-FLT-PET uptake dynamics and overall survival predictions for patients with recurrent high-grade glioma on bevacizumab therapy
Schwarzenberg J, Czernin J, Cloughesy T, Geist C, Silverman D, Satyamurthy N, Phelps M, Chen W, J Nucl Med., 1/1/2011
. Effects of trigeminal nerve stimulation on regional brain activity in depression
Silverman D, Geist C, Cook I, DeGiorgio C, Miller P, Susselman M, Schrader L, J Nucl Med, 1/1/2011
Changes in regional brain metabolism following initial therapy for breast cancer.
Pomyala K, Geist C, Silverman D, Kwan L, Bower J, Irwin M, Czernin J, Phelps M, Ganz P., J Nucl Med., 1/1/2011
Regional cerebral activity associated with self-perception of memory problems in brains of breast cancer patients soon after adjuvant chemotherapy
Geist C, Pomykala K, Silverman D, Ganz P, Kwan L, Bower J, Irwin M, Czernin J, Phelps M, Castellon S., J Nucl Med., 2011
Altered amino acid uptake associated with chemotherapy and radiation exposure in subjects with primary brain tumors.
Geist C, Yu A, Chen W, Cloughesy T, Munagala N, Robertson C, Czernin J, Phelps M, Silverman D, J Nucl Med., 1/1/2011
Regional brain metabolism and circulating inflammatory cytokines in breast cancer patients after adjuvant chemotherapy
Silverman D, Geist C, Pomykala K, Breen E, Bower J, Kwan L, Irwin M, Czernin J, Phelps M, Ganz P, J Nucl Med, 1/1/2011
Differential effects of estrogen preparation on changes in regional cerebral metabolism in postmenopausal women.
Rasgon NL, Kenna HA, Wroolie T, Geist C, Epel E, Kroenke C, Lin J, Silverman D, Neuropsychopharmacology, 2011
Regional PET Activation with Trigeminal Nerve Stimulation in Major Depression
Cook IA, Schrader ML, Geist CL, Silverman DHS, Miller PR, Susselman MK, DeGiorgio CM, ) American Society of Clinical Psychopharmacology: New Clinical Drug Evaluation Unit., 1/1/2011
18F-FLT-PET uptake dynamics and overall survival predictions for patients with recurrent high-grade glioma on bevacizumab therapy
Schwarzenberg J, Czernin J, Cloughesy T, Ellingson B, Geist C, Phelps M, Chen W, Neuro-oncology, 1/1/2011
Metabolic tumor volume changes by amino acid PET tracer FDOPA is predictive of treatment response in patients with recurrent high-grade gliomas on bevacizumab therapy.
Schwarzenberg J, Cloughesy T, Czernin J, Geist C, Phelps M, Chen W, Neuro-oncology, 1/1/2011
Regional brain metabolism and peripheral cytokine levels following adjuvant chemotherapy
21. Silverman DH, Geist CL, Yang CC, Bower JE, Lee SK, Kwan L, Castellon SA, Czernin J, Ganz P, J Nucl Med., 2010
Prognostic value of 18F-FDOPA PET in patients with treated low-grade gliomas
Geist C, Cloughesy T, Czernin J, Silverman DHS, Satyamurthy N, Phelps M, Lai A, Nghiemphu L, Chen W., J Nucl Med., 1/1/2010
Relationships between neuropsychological function and brain activity following adjuvant chemotherapy
Yang CC, Geist CL, Castellon S, Silverman DHS, Lee SK, Kwan L, Czernin J, Ganz P, J Nucl Med., 1/1/2010
Changes in regional brain metabolism following aromatase inhibitor therapy in postmenopausal women
Silverman DHS, Lee SK, Geist CL, Yang CC, Togawa K, Katheria VV, Czernin J, Phelps ME, Hurria A., J Nucl Med., 1/1/2010
Correlation of FDOPA-PET uptake with proliferative activity and malignancy grade in brain tumors
Fueger B, Geist C, Silverman D, Czernin J, Satyamurthy N, Lai A, Cloughesy T, Phelps M, Chen W., J Nucl Med., 2009
Verbal memory performance of postmenopausal women on estradiol therapy is positively correlated with regional brain metabolism in receptive language and auditory assoc...
Geist CL, Silverman DH, Kenna H, Rasgon NL., J Nucl Med., 2009
Join now to see all